Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [211]

Real-world evidence of the use of carfilzomib to refractory to lenalidomide...

Prof Evangelos Terpos - University of Athens, Athens, Greece

$Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients ( Prof Evangelos Terpos - University of Athens, Athens, Greece )$

Real world management of multiple myeloma patients

Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina

Real world management of multiple myeloma patients ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )

Updates in geriatric medical oncology from SIOG meeting

Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador...

Updates in geriatric medical oncology from SIOG meeting ( Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico )

Priorities of cancer research in Nepal

Dr Soniya Dulal - BP Koirala Institute of Health Sciences, Dharan, Nepal

Priorities of cancer research in Nepal ( Dr Soniya Dulal - BP Koirala Institute of Health Sciences, Dharan, Nepal )

Management of infection risk to myeloma patients during the COVID pandemic

Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology...

Management of infection risk to myeloma patients during the COVID pandemic ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )

Lenalidomide combination for multiple myeloma

Prof Xavier Leleu - Hôpital La Mileterie CHU, Poitiers, France

Lenalidomide combination for multiple myeloma ( Prof Xavier Leleu - Hôpital La Mileterie CHU, Poitiers, France )

Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma

Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain

Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma ( Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain )

Latest updates to the ESMO bone health guidelines

Prof Robert Coleman - University of Sheffield, Sheffield, UK

Latest updates to the ESMO bone health guidelines ( Prof Robert Coleman - University of Sheffield, Sheffield, UK )

Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort

Professor Jean-Yves Blay and Professor Florence Duffaud

Exploring TKIs in metastatic sarcomas: Results of REGOBONE osteosarcoma cohort ( Professor Jean-Yves Blay and Professor Florence Duffaud )

D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk...

Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands

D-VTd in transplant-eligible newly diagnosed MM: Subgroup analysis of high-risk patients in CASSIOPEIA ( Prof Pieter Sonneveld - Erasmus MC Cancer Institute, Rotterdam, Netherlands )

A phase 1b study of once-weekly KRd in patients with newly diagnosed multiple...

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

A phase 1b study of once-weekly KRd in patients with newly diagnosed multiple myeloma ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

Synthesis, preclinical analysis, and first-inhuman phase I imaging of 89Zr...

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

Synthesis, preclinical analysis, and first-inhuman phase I imaging of 89Zr-DFOdaratumumab for CD38 targeted imaging of myeloma ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

More from ecancer